INTECH - MARS 2012 - Au sommaire: Retrospective Analysis of Leishmaniasis in Central Tunisia: An Update on Emerging Epidemiologi Edited by Alfonso J. Rodriguez-Morales, ISBN 978-953-51-0274-8, 576 pages, Publisher: InTech, Chapters published March 16, 2012 under CC BY 3.0 licenseDOI: 10.5772/1335 Edited Volume Tropical Medicine has emerged and remained as an important discipline for the study of diseases endemic in the tropic, particularly those of infectious etiology.
Portail élev CN INTECH - AVRIL 2012 - Zoonosis. Au sommaire:Visceral Leishmaniosis: An Old Disease with Continuous Impact on Public Health Edited by Jacob Lorenzo-Morales, ISBN 978-953-51-0479-7, 448 pages, Publisher: InTech, Chapters published April 04, 2012 under CC BY 3.0 licenseDOI: 10.5772/2125 Edited Volume Zoonotic diseases are mainly caused by bacterial, viral or parasitic agents although "unconventional agents" such as prions could also be involved in causing zoonotic diseases. Many of the zoonotic diseases are a public health concern but also affect the production of food of animal origin thus they could cause problems in international trade of animal-origin goods. A major factor contributing to the emergence of new zoonotic pathogens in human populations is increased contact between humans and animals. Chapter 1 Managerial Epidemiology and Zoonoses: Application of Managerial Epidemiology in Control of Zoonotic Disease in Bosnia and Herzegovina by Semra Čavaljuga Chapter 2 Health Adjusted Life Years (HALY) - A Promising Measure to Estimate the Burden of Zoonotic Diseases on Human Health?
SAO PAULO RESEARCH FOUNDATION 15/08/12 The identification of a new target for fighting Leishmaniasis An enzyme from a metabolic pathway of the parasite that causes the disease could be a target for new medications that would impede Leishmania growth and infection in humans August 15, 2012 By Elton Alisson Agência FAPESP – Pentavalent antimonial drugs are considered to be expensive, toxic and ineffective in the current treatment of leishmaniasis, which is a chronic disease caused by protozoan parasites from the genus Leishmania. Leishmaniasis is considered a “neglected disease” by the World Health Organization (WHO) because it affects poor populations in developing countries and therefore does not receive significant attention from the pharmaceutical industry. A study performed by researchers at the Universidade de São Paulo Institute of Biological Sciences Physiology Department (IB-USP) and the University of Washington (U.S.) The results of the study, which was funded by FAPESP through a Thematic Project, were published in PLoS One. Inhibiting arginase
NATURE 08/03/13 Leishmaniasis drug fails a fifth of patients - High failure rate of front-line therapy puts eradication campaign Andrew Caballero-Reynolds/Getty Images A young boy at a clinic in Kacheliba, Kenya, stares out over an array of leishmaniasis medication — the most common of which is associated with a high rate of relapse. One in five people treated for a serious form of leishmaniasis in Nepal relapse after a year. The finding, published in Clinical Infectious Diseases last month1, is “an alarming signal” for campaigns to eliminate the neglected disease, say researchers. Leishmaniasis, which is caused by the parasitic microorganism Leishmania donovani and spread by female sandflies (Phlebotomus argentipes), is endemic in 88 countries, of which 72 are developing, according to the World Health Organization (WHO). The disease causes skin ulcers, swelling of spleen and liver, and erosion of the mucous linings of the nose, mouth and throat, and can be fatal if left untreated. Relapse rate Not good enough But Dujardin says that the combination therapy could be problematic.
Int. J. Environ. Res. Public Health 2013, 10(8), 3172-3191; Linking Climate to Incidence of Zoonotic Cutaneous Leishmaniasis (L. Open AccessThis article isfreely availablere-usable Article Lahouari Bounoua 1,* , Kholoud Kahime 2 , Leila Houti 3 , Tara Blakey 4 , Kristie L. , Ping Zhang 1,6 , Marc L. , Kurtis J. , Claire Dudek 8 , Salah A. , Mohammed Messouli 10 , Baghdad Makhlouf 11 , Abderrahmane El. and Ali Boumezzough 2 * Author to whom correspondence should be addressed. Received: 3 May 2013; in revised form: 12 July 2013 / Accepted: 13 July 2013 / Published: 31 July 2013 Abstract: Shifts in surface climate may have changed the dynamic of zoonotic cutaneous leishmaniasis (ZCL) in the pre-Saharan zones of North Africa. Keywords: cutaneous leishmaniasis; surface climate indicators; incidence; climate; NDVI; North Africa MDPI and ACS Style Bounoua, L.; Kahime, K.; Houti, L.; Blakey, T.; Ebi, K.L.; Zhang, P.; Imhoff, M.L.; Thome, K.J.; Dudek, C.; Sahabi, S.A.; Messouli, M.; Makhlouf, B.; Laamrani, A.E.; Boumezzough, A. AMA Style Chicago/Turabian Style
HORSETALK 16/11/12 Rare human parasite found in US horse for first time By Horsetalk.co.nz on Nov 16, 2012 in News A rare and potentially fatal parasite never before found in North America has been identified in a Florida horse. University of Florida veterinarians identified the parasite, called Leishmania siamensis, in the summer of 2011. UF veterinarian Sarah Reuss, VMD, and colleagues have identified a rare, potentially fatal species of parasite in a Florida horse. This particular parasite species has previously been found only in Thailand and parts of Europe. The discovery raises awareness of how widespread the parasite is and suggests a need for watchfulness regarding potential transmission to humans, the researchers said. “We now know the parasites that cause this disease also exist here in the US and that we have some insect, presumably the sandfly, that is capable of transmitting the disease,” said Sarah Reuss, a clinical assistant professor of large animal medicine at the the university’s College of Veterinary Medicine. Under: biosecurity
IRANIAN JOURNAL OF PARASITOLOGY - 2013 - Evaluation of the Leishmanicidal and Cytotoxic Potential of Essential Oils Derived From Ten Colombian Plants An Bras Dermatol. 2013 Sep-Oct; 88(5): 748–753. American cutaneous leishmaniasis: epidemiological profile of patients treated in Londrina from 1998 to 2009*
INTECH 19/03/14 Leishmaniasis - Trends in Epidemiology, Diagnosis and Treatment Edited by David M. Claborn, ISBN 978-953-51-1232-7, 534 pages, Publisher: InTech, Chapters published March 19, 2014 under CC BY 3.0 licenseDOI: 10.5772/57067 Edited Volume Of all the parasitic diseases, leishmaniasis is one of the most diverse, with a variety of manifestations, from relatively minor cutaneous lesions to deadly visceral infections. It is also widespread, causing human disease in the Americas, Asia, Europe and Africa. Chapter 1 Environmental Changes and the Geographic Spreading of American Cutaneous Leishmaniasis in Brazil by Elizabeth F.